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Human cardiac stem cells (hCSC) express a portfolio of plasma membrane receptors that are 
involved in the regulatory auto/paracrine feedback loop mechanism of activation of these cells, and 
consequently contribute to myocardial regeneration. In order to attain a comprehensive description of 
hCSC receptome and overcoming the inability demonstrated by other technologies applied in receptor 
identification, mainly due to the transmembrane nature, high hydrophobic character and relative low 
concentration of these proteins, we have exploited and improved a proteomics workflow. This 
approach was based on the enrichment of hCSC plasma membrane fraction and addition of pre-
fractionation steps prior to MS analysis. More than one hundred plasma membrane receptors were 
identified. The data reported herein constitute a valuable source of information to further understand 
cardiac stem cells activation mechanisms and the subsequent cardiac repair process. Data have been 
deposited to the ProteomeXchange with identifier PXD001117 
Cardiovascular diseases (CVDs) are the leading cause of death worldwide, namely ischaemic heart 
disease that was responsible for the highest number of deaths during the past decade according to 
the World Health Organization (WHO). Moreover, WHO estimates that CVDs will remain the single 
leading cause of death, reaching about 23 million deaths by 2030 [1]. Particularly, acute myocardial 
infarction (AMI) severely affects patients’ heart muscle and microvasculature, critically decreasing the 
number of functional cardiomyocytes (CM). Stem cell and protein based therapies are promising 
therapeutic strategies for cardiac repair since it was found that the adult myocardium homes a minor 
population of resident cardiac stem cells (CSC) capable to contribute to contractile myocardium 
regeneration [2-4]. The surviving CM under pathological stress produce a set of growth factors (GF) 
and cytokines that promote CM survival and activate endogenous CSC niches. Consequently, an 
auto/paracrine loop is triggered to maintain the GF production, which stimulates CSC activation and 
differentiation into new CM, endothelial and smooth muscle cells able to repair the damaged 
myocardium [5, 6].  
Although CSC activation is responsible for a continuous, but low level, repopulation of the 
myocardium, it is not robust and durable enough to have significant beneficial 
physiological/anatomical impact in severe and acute myocardial losses, as occurs in most AMI 
www.proteomics-journal.com Page 3 Proteomics 
 
episodes [7]. However, local administration of GF has been shown to be efficient in activating CSC, 
improving cardiac output post-AMI through the formation of new vascularized and functional 
autologous myocardium. Additionally, it was also demonstrated in animal models that GF 
administration is a very effective way to promote the regeneration of myocardium after ischemia [6, 8, 
9]. Therefore, it is of outmost importance to define the GF receptors involved in the paracrine-
autocrine feedback loop between CM and hCSC, to disclose the signaling pathways beneath 
myocardial regeneration. 
In this study we investigated the profile of proteins expressed in hCSC, namely at the receptome 
level, using an optimized proteomics pipeline. Proteomics methodologies now available enable the 
high-throughput identification of almost entire proteomes and sub-proteomes of interest and 
assessment of the complexity of proteins present in different cells, unveiling their potential biological 
roles. Moreover, technological advances, mainly in mass spectrometry (MS) instrumentation, resulted 
in a substantial increase in plasma membrane proteins representation in large data sets [10-12]. 
Other attempts for partial hCSC receptome characterization using specific proteomics techniques 
have been previously reported. Moscoso et al. described an approach based on biotinylation of 
plasma membrane proteins where only 36 proteins were identified [13]. Moreover, most of the 
proteins listed are just plasma membrane associated or contained a single transmembrane domain 
and only a few receptors were identified. To overcome this inability to efficiently identify receptors, we 
have integrated different protocols and approaches into a workflow based on optimized plasma 
membrane protein fraction preparation, pre-fractionation and state-of-the-art MS. 
Enriched plasma membrane fractions: hCSC isolation and cell characterization were previously 
reported [13, 14]. After expansion, cells were harvested (passage 6/7) by scraping and washed twice 
with PBS. Cell pellets (5x10
6 
cells/pellet) were resuspended in lysis buffer and lysed with 30 passes 
through the 301/2 Gauge needle, at 4ºC. Enriched plasma membrane fractions were obtained as 
described by Dornemeyer et al. [12], and finally rinsed twice with cold water at 20,000 x g, 30 min at 4 
ºC (detailed protocol described in supporting information document 1). Obtained fractions were 
separated in a SDS-PAGE gel (~25 µg/lane) and the presence of protein markers for other subcellular 
compartments/intracellular membranes was detected by Western-blot (supporting information 
document 2). 
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1D-MALDI-TOF/TOF: To proceed with hCSC receptome characterization, an in-gel proteomics 
approach was initially tested. An entire gel lane (~50 µg per lane) was excised and sliced in 60 bands 
that were independently digested (trypsin, Promega), desalted and concentrated sequentially in 
custom-made chromatographic microcolumns with increasing hydrophobic material (Poros R2, Poros 
R3 and graphite powder) [15]. The flow-throughs were directly spotted on a MALDI plate using 0.6 µL 
of 5 mg/mL α-Cyano-4-hydroxycinnamic acid (Sigma) and analyzed on a 4800 Plus MALDI-TOF/TOF 
analyser using 4000 Series Explorer Software v.3.5.3 (ABSciex). The top 15 precursor ions from the 
MS spectra were selected for MS/MS analysis. The MS and MS/MS data were analyzed in combined 
search mode (MS+MS/MS) using GPS Explorer Software v.3.6 (ABSciex) and MASCOT. The search 
parameters considered were: monoisotopic peptide mass values, maximum precursor mass tolerance 
of 50 ppm and a maximum fragment mass tolerance of 0.3 Da. The searches were performed against 
SwissProt database (Homo sapiens, 20319 sequences). One missed cleavage was allowed; 
carboxamidemethylation of cysteines and oxidation of methionines were set as fixed and variable 
modifications, respectively. Protein identification was only accepted when significant protein homology 
scores were obtained (p<0.05) and at least one peptide was fragmented with a significant individual 
ion score (p<0.05). More than 120 unique proteins were identified (Supporting Information Table ST1) 
using this approach, only the more abundant proteins in each band were identified. In order to access 
the hydrophobicity and number of transmembrane domains of the identified proteins, bioinformatics 
tools were used to calculate putative transmembrane domains (TMD) and GRAVY index 
(http://www.cbs.dtu.dk/services/TMHMM/ and http://www.bioinformatics.org/sms2/protein_gravy.html). 
The number of transmembrane proteins was still very small (43 proteins), and from those only 3 were 
classified as receptors (Figure 1). While the enrichment in membrane proteins is demonstrated, a 
large contamination with proteins from other organelles is also observed. From this analysis and in 
accordance with previous reports in the literature [16] we confirmed that this was not the most 
effective strategy to identify less abundant proteins, and specifically those with more transmembrane 
domains/receptors.  
nanoLC-LTQ-Orbitrap: To improve the numbers of receptors accessed we have proceeded with a 
different approach comprising a nanoLC fractionation previous to MS analysis. hCSCs membrane 
enriched fractions were prepared as described above and loaded (~50 µg) on a SDS-PAGE gel for 
cleaning and trypsin digestion, as described [17]. Proteins were concentrated in a single gel band that 
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was visualized by colloidal-Coomassie staining, excised, and cut in 15-20 small pieces. Sample was 
subjected to reduction and alkylation, and digested with trypsin. TFA was added to a final 
concentration of 1% and the peptides were desalted onto HLB Oasis cartridges and dried-down. 
Sample tryptic peptides (3 µg per injection) were analyzed by LC-MS, using the LTQ-Orbitrap XL 
(Thermo Scientific). Proteins were identified with Proteome Discoverer 1.3 (Thermo Scientific); two 
mixed cleavages were allowed, carboxamidemethylation of cysteines and oxidation of methionines 
were set as fixed and variable modifications, respectively, and an error of 20 ppm or 1.2 Da was set 
for full MS or MS/MS spectra searches, respectively. Peptide identifications were validated using the 
probability ratio and the refined FDR method [18, 19]. Peptide identifications were firstly filtered out 
using 0.05 FDR prior to the application of subsequent, more restrictive criteria (see below). Protein 
classification was performed using Ingenuity Pathway Analysis software (IPA). GRAVY indexes and 
TMDs were investigated for these proteins as described above (Figure 1). A list of more than 600 
proteins was obtained, including 218 proteins with TMDs and 23 receptors (e.g. IGF2R, ABCC1 …) 
(Figure 1; Supporting Information Table ST2). Eighty of the proteins identified were also found in our 
MALDI-TOF/TOF experiment, and 18 were already described in Moscoso et al. study [13]. CD71, 
MMP-14, and a few others were consistently identified. Proteins described to be involved in the 
cardiac function (sarcomeric proteins) were also found. Clear improvements in hCSCs receptome 
analysis protocol were accomplished, although we pursued a more complete dataset covering 
proteins with more TMDs and better representation of receptors. 
MCX-nanoLC-LTQ-Orbitrap: Addition of an extra pre-fractionation step prior to nanoLC was tested. 
Enriched plasma membrane fractions where digested as above and the resulting peptides further 
fractionated through an offline mixed-mode cationic exchange (MCX) chromatography prior to MS 
analysis. Six independent fractions obtained by MCX were then analyzed by nanoLC-MS (as 
described above). Data show a significant enrichment not only at the level of the total number of 
identified proteins (2297, Figure 1), but also confirmed that the pre-fractionation step was critical to 
access proteins with more TMDs. More than 350 proteins were assigned as plasma membrane 
proteins, including 92 receptors and proteins with numerous TMDs. Cell surface markers as myoferlin, 
endoglin and receptors (e.g. EGFR and Frizzled-6) were identified (Supporting Information Table 
ST3).  
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This proteomics platform has shown to be efficient in achieving a more complete description of the 
receptors present in hCSC membrane. Furthermore, the assessment of hCSC receptome was done 
using an Orbitrap Elite instrument (Thermo Scientific), its higher resolving power and sensitivity, 
together with a long 6 hours nanoLC run, improved and simplified sample analysis. Three replicates 
of enriched plasma membrane fraction, from three independent hCSC cultures (RI, RII and RIII) were 
analyzed. As before, proteins were identified with Proteome Discoverer 1.3, but a tolerance of 100 
ppm or 1.2 Da was set for full MS or MS/MS spectra searches, respectively.  A subsequent filter of 10 
ppm tolerance for full MS was used, and peptide identifications validated using the probability ratio 
and the refined FDR method. Because numerous proteins were identified with one peptide only, an 
additional filter of FDR < 0.01 was applied to these proteins. A total of 3483 unique proteins were 
identified in the sum of the three runs, and among those 1242 were consistently identified in the three 
replicates (Figure 2; Supporting Information Table ST4), representing a common core of proteins 
which was consistently identified (Figure 2B). Nevertheless, a large number of proteins were identified 
in two (986 proteins) or in only one (1255 proteins) of the replicates. A substantial proportion (1318) of 
the annotated proteins contained one or more predicted TMDs, and from these 531 were identified in 
all triplicates, corresponding to approximately 40% of proteins identified in each list (Figure 3; 
Supporting Information Table ST4). These results reflect a significant enrichment in transmembrane 
proteins, as only approximately 27% of the total human proteome represent alpha-helical 
transmembrane proteins (containing one or more putative TMDs)[20]. Figures 2 and 3 summarize the 
dataset of proteins identified, namely concerning the presence of TMDs, cellular location and receptor 
function. As expected, although enrichment in plasma membrane proteins was achieved, a large 
contamination with proteins from other subcellular membranes was also present; this is in agreement 
with previous literature [11, 12, 16]. Nevertheless, by applying this subproteomic analysis to hCSC 
enriched plasma membrane fraction, we were able to achieve a larger coverage of hCSC receptome 
characterization. Up to this point, the list of receptors (and corresponding interaction partners) known 
to be relevant for hCSC activation is only a small fraction of the whole pool of molecules involved in 
this intricate process. Many others have escaped detection by the low sensitivity and target directed 
technologies used until now [13, 21, 22]. As referred before, the relatively low abundance of 
membrane proteins/receptors and the increased difficulty to identify integral membrane proteins due 
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to their hydrophobic nature has resulted in their under-representation in large proteomic studies. We 
took advantage of the combination of improved sample preparation options, nanoLC performance and 
state-of-the-art MS instrumentation, to translate it into a substantial increase in receptors identification 
in our dataset. This work and the data generated will critically contribute to the elucidation of the 
players beyond the mechanisms of hCSC activation and differentiation. Moreover, we are currently 
applying this optimized methodology, for identification of receptors in the characterization of other 
human cell types (e.g. mesenchymal stem cells). The reported workflow may constitute a key tool in 
the characterization of different human stem cell types (and other target cells) contributing to the 
interpretation of important biological mechanisms still undefined.  
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Figure 1 – Optimization of hCSC receptome analysis. A- Number of predicted TMDs and GRAVY 
values of the identified proteins using three different approaches: 1D-MALDI-TOF/TOF, nanoLC-LTQ-
Orbitrap and MCX-nanoLC-LTQ-Orbitrap.  B- MCX-nanoLC-LTQ-Orbitrap approach yielded a higher 
number of total proteins identified, including higher number of proteins with predicted TMDs and 
receptors. 
Proteins Total TMDs ≥ 1 P.Membrane Receptor
1D-MALDI-TOF/TOF 125 43 13 3
nanoLC-LTQ-Orbitrap 601 218 110 23
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Figure 2 – hCSC receptome analysis using nanoLC-Orbitrap Elite. (A) Graphical representation of the 
number of proteins identified in hCSC enriched membrane fraction, *Classification according to IPA 
software; (B) Venn diagram representing the number of proteins identified in the three replicates 
(http://bioinfogp.cnb.csic.es/tools/venny/); (C) Classification and representativity of proteins 
identified in hCSC enriched membrane fraction.  
 
 
Number of identified proteins
Total TMDs Plasma Membrane* Receptors*
Total list 3483 1318 (37.8%) 663 (19.0%) 167 (4.8%)
RI 2475 970 (39.2%) 491 (19.8%) 123 (5.0%)
RII 2248 914 (40.7%) 416 (18.5%) 93 (4.1%)
RIII 2230 870 (39.0%) 441 (19.8%) 104 (4.7%)
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Figure 3 – (A) Subcellular location of the identified proteins in the three replicates according to IPA 
software database (NP- not present). (B) Number of predicted TMDs vs GRAVY values of the 
identified proteins. The methodology used allowed the identification of 1318 (531 common to all 
replicates) integral membrane proteins and also highly hydrophobic ones (645 proteins with GRAVY > 
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